510(k) K953875
K953875 is an FDA 510(k) premarket notification submitted by In-Line Diagnostics Corp. for the device "CRIT-LINE HEMATOCRIT ALERT (MODIFICATION)". The FDA issued a decision of Substantially Equivalent on July 23, 1996. The device falls under product code MQS (System, Hemodialysis, Access Recirculation Monitoring), a Class II device regulated under 21 CFR 876.5820. In-Line Diagnostics Corp. has at least 7 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 23, 1996
- Date Received
- June 28, 1995
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Hemodialysis, Access Recirculation Monitoring
- Device Class
- Class II
- Regulation Number
- 876.5820
- Review Panel
- GU
- Submission Type